PIKTOR

Faeth Therapeutics Highlights PIKTOR Strategy Ahead of Phase 2 Data

AUSTIN, Texas — September 8, 2026 Faeth Therapeutics announced plans to host a virtual key opinion leader (KOL) event...

By cGxPwire Editor
September 9, 2026

Bio-Pharma

Faeth Therapeutics Gains FDA Fast Track for PIKTOR

Austin, Texas — August 17, 2026 Faeth Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...

By cGxPwire Editor
August 18, 2026

Bio-Pharma

Faeth Therapeutics to Present PIKTOR PK/PD Data

AUSTIN, Texas, August 7, 2026 Faeth Therapeutics announced that it will present new pharmacokinetic/pharmacodynamic (PK/PD) modeling and translational research...

By cGxPwire Editor
August 8, 2026

.Clinical

Sensei Doses First Patient in PIKTOR Breast Trial

BOSTON, May 5, 2026 Sensei Biotherapeutics, Inc. has announced the first patient dosing in its Phase 1b/2 clinical trial...

By cGxPwire Editor
May 6, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Faeth Therapeutics Highlights PIKTOR Strategy Ahead of Phase 2 Data

Faeth Therapeutics Gains FDA Fast Track for PIKTOR

Faeth Therapeutics to Present PIKTOR PK/PD Data

Sensei Doses First Patient in PIKTOR Breast Trial